Multiple sclerosis.
Boggild
Mike
M
The Walton Centre for Neurology and Neurosurgery, Liverpool, UK.
Ford
Helen
H
D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000009:adverse effects; D004333:Drug Administration Routes; D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000008:administration & dosage / Q000009:adverse effects; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects; D020528:Multiple Sclerosis, Chronic Progressive / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D000068576:Interferon beta-1b; D016899:Interferon-beta; D000324:Adrenocorticotropic Hormone; D008775:Methylprednisolone; D000068556:Interferon beta-1a